Today: March 28, 2017, 10:11 am

New Market Report Now Available: United Kingdom Orthobiologics Market Outlook to 2020

Fast Market Research recommends "United Kingdom Orthobiologics Market Outlook to 2020" from GlobalData, now available 2014-03-18 14:24:28
GlobalData's new report, "United Kingdom Orthobiologics Market Outlook to 2020", provides key market data on the United Kingdom Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

Full Report Details at
- ..

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


* Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
* Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
* 2012 company shares and distribution shares data for each of the market categories.
* Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics market.
* Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to Get this Report

* Develop business strategies by identifying the key market segments poised for strong growth in the future.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the market.
* Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: Medtronic, Inc., DePuy Companies, Sanofi, DJO Finance LLC, Baxter International Inc., Orthofix International N.V., Wright Medical Group, Inc., Biomet, Inc., Smith & Nephew Plc, Globus Medical, Inc., Anika Therapeutics, Inc., NuVasive, Inc., Alphatec Holdings, Inc., Stryker Corporation, Seikagaku Corporation

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United Kingdom
3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2005-2012
3.2 Orthobiologics Market, United Kingdom, Revenue ($m), 2012-2020
3.2.1 Bone Graft Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2005-2012
3.2.2 Bone Graft Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2012-2020
3.3 Orthobiologics Market, United Kingdom, Volume (Units), 2005-2012
3.4 Orthobiologics Market, United Kingdom, Volume (Units), 2012-2020
3.4.1 Bone Graft Substitutes Market, United Kingdom, Volume (Units), by Segment, 2005-2012
3.4.2 Bone Graft Substitutes Market, United Kingdom, Volume (Units), by Segment, 2012-2020
3.5 Orthobiologics Market, United Kingdom, Average Price ($), 2005-2020
3.6 Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012
3.7 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2011-2012
4 Overview of Key Companies in United Kingdom Orthobiologics Market
4.1 Medtronic, Inc.
4.1.1 Company Overview
4.2 DePuy Companies
4.2.1 Company Overview
4.3 Sanofi
4.3.1 Company Overview
4.4 DJO Finance LLC
4.4.1 Company Overview
4.5 Baxter International Inc.
4.5.1 Company Overview
4.6 Orthofix International N.V.
4.6.1 Company Overview
4.7 Wright Medical Group, Inc.
4.7.1 Company Overview
4.8 Biomet, Inc.
4.8.1 Company Overview
4.9 Smith & Nephew Plc
4.9.1 Company Overview
4.10 Globus Medical, Inc.
4.10.1 Company Overview
4.11 Anika Therapeutics, Inc.
4.11.1 Company Overview
4.12 NuVasive, Inc.
4.12.1 Company Overview
4.13 Alphatec Holdings, Inc.
4.13.1 Company Overview
4.14 Stryker Corporation
4.14.1 Company Overview
4.15 Seikagaku Corporation
4.15.1 Company Overview
5 Orthobiologics Market Pipeline Products
6 Financial Deals Landscape
6.1 Asset Transactions
6.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million
6.2 Partnerships
6.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital

Full Table of Contents is available at:

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Press Information

Published by
Bill Thompson

# 970 Words
Related Articles
More From Health
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo [..]
PromarkerD Predictive Diagnostics for DKD to Roll-out [..]
PERTH, AUSTRALIA, Mar 22, 2017 - (ACN Newswire) - Proteomics International Laboratories Ltd ('PILL'; ASX: PIQ), a world leader [..]
Do Prostalgene Drops Help To Restore Prostate [..]
Prostate enlargement is among the most common health problems for men over 50. With age the incidence of this condition [..]
Is OnycoSolve Spray The Key To Obliterating [..]
Toenail fungus is an undesirable but stubborn infection that comes with sweating, itching, cracking and scaling of the feet, inflammations, [..]
New Research reveals Asia poised as Preferred [..]
SYDNEY, Mar 10, 2017 - (ACN Newswire) - Frost & Sullivan has released its latest white paper, 'Asia: Preferred Destination for [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.